Singapore surgeon treats severe eye damage using mouth tissue, donated stem cells

Patients suffer from a rare, serious disorder of the skin and mucous membranes. Read more at straitstimes.com. Read more at ...
Newsable Asianet News on MSN

Delhi man's life saved after OTC drugs cause rare skin condition

A 65-year-old Delhi man developed a life-threatening skin condition, Stevens-Johnson Syndrome, after self-medicating for fever. Doctors at Aakash Healthcare saved his life after a 20-day intensive ...
Rutland Herald

Alpha Cognition Reports Positive Top-Line Results from BEACON Real-World Study of ZUNVEYL® in Alzheimer’s Disease

Alpha Cognition Inc. (NASDAQ: ACOG) (“Alpha Cognition”, “ACI”, or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today ...
Healio

Toddler with progressive blistering on face

In 1973, a previously healthy 4-year-old U.S. military-dependent boy presented to a local clinic in Okinawa for evaluation ...
Everyday Health on MSN

Scleral lenses for managing dry eye disease

Learn how scleral lenses manage severe dry eye disease by creating a hydrating tear reservoir, and about the fitting process, ...

BeOne Medicines Receives Positive Reimbursement Recommendations from CDA-AMC and INESSS for TEVIMBRA in First-Line Nasopharyngeal Carcinoma

CNW/ - BeOne Medicines, a global oncology company, today announced that Canada's Drug Agency (CDA-AMC) and the Institut national d'excellence en santé et ...

They were lucky to survive — but one question still haunts them

When is a lucky escape not so lucky? Watch Insight episode Lucky Escapes Tuesday 26 May at 8.30PM on SBS or SBS On Demand. When Bethany Clarke, 28, was travelling around Southeast Asia with her best ...

Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete ...

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...
Las Vegas Sun

IMFINZI® (durvalumab) approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer

AstraZeneca’s IMFINZI ® (durvalumab) in combination with Bacillus Calmette-Guérin (BCG) induction and maintenance therapy has been approved in the US for the treatment of adult patients with BCG-naïve ...
Public Broadcasting Service (PBS)

What's next for the War Powers Resolution on Iran? PolitiFact explains

The House and Senate have advanced war powers resolutions aimed at curbing President Donald Trump from continuing the war in ...

Alpha Cognition Inc. Reports First Quarter 2026 Financial Results and Provides Operational Update

Alpha Cognition presented new clinical data on ZUNVEYL at the American Association of Geriatric Psychiatrists (AAGP) in April 2026 and is presenting at the Neuroscience Education Institute (NEI) ...